Tabanao, Carlos J.

HRN: 06-00-38  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/07/2025
CEFUROXIME 750MG (VIAL)
10/07/2025
10/14/2025
IV
750 MG
Q8HRS
SQUAMOUS CELL CARCINOMA OF THE TONGUE

 Indication:  ProphylaxisEmpiric    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Non-compliant To Guidelines